Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intermittent androgen blockade in prostatic carcinoma].

V Vachalovský1, J Dvorácek

  • 1Urologická klinika 1. LF UK a VFN, Praha. j.vit@email.cz

Casopis Lekaru Ceskych
|February 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Laparoscopic pyeloplasty in adults--mid-term results in 32 laparoscopic pyeloplasties during 2003-2008].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2009
Same author

[Mid-term outcomes and survival rates in patients with radical retropubic prostatectomy (RRP) under current Czech healthcare system].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2009
Same author

[Outcomes of transperitoneal laparoscopic nephrectomy for renal adenocarcinoma].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2009
Same author

Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?

Urologia internationalis·2008
Same author

Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.

Urology·2008
Same author

[New aspects in prostate cancer therapy].

Casopis lekaru ceskych·2007
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Intermittent endocrine therapy for prostate cancer may extend survival and improve quality of life by reducing side effects. Further studies are needed to confirm prolonged survival benefits.

Area of Science:

  • Oncology
  • Endocrinology

Context:

  • Prostate cancer treatment often involves continuous androgen ablation, leading to side effects.
  • Intermittent endocrine therapy (IET) offers an alternative approach to managing prostate cancer.

Purpose:

  • To evaluate the efficacy of intermittent endocrine treatment (IET) in prolonging survival and improving quality of life for prostate cancer patients.
  • To assess the impact of IET on delaying progression to androgen independence and mitigating treatment side effects.

Summary:

  • IET involves cycles of treatment and off-therapy intervals, with a recommended therapeutic period of 6-9 months.
  • The mean off-therapy interval is approximately 50% of the treatment duration.
  • The study observed a mean time to disease progression of 32 months.

Related Experiment Videos

Impact:

  • IET demonstrates potential for inducing apoptotic regressions and improving quality of life, including sexual function.
  • While promising, definitive conclusions on prolonged survival require ongoing randomized studies.